WO2011142573A3 - Ｗｔａ를 유효성분으로 함유하는 백신 조성물 - Google Patents

Ｗｔａ를 유효성분으로 함유하는 백신 조성물 Download PDF

Info

Publication number
WO2011142573A3
WO2011142573A3 PCT/KR2011/003450 KR2011003450W WO2011142573A3 WO 2011142573 A3 WO2011142573 A3 WO 2011142573A3 KR 2011003450 W KR2011003450 W KR 2011003450W WO 2011142573 A3 WO2011142573 A3 WO 2011142573A3
Authority
WO
WIPO (PCT)
Prior art keywords
wta
vaccine composition
active ingredient
composition containing
staphylococcus aureus
Prior art date
Application number
PCT/KR2011/003450
Other languages
English (en)
French (fr)
Other versions
WO2011142573A2 (ko
Inventor
이복률
박근화
구로카와겐지
Original Assignee
부산대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 부산대학교 산학협력단 filed Critical 부산대학교 산학협력단
Publication of WO2011142573A2 publication Critical patent/WO2011142573A2/ko
Publication of WO2011142573A3 publication Critical patent/WO2011142573A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 WTA (wall teichoic acid)를 유효성분으로 함유하는 백신 조성물에 관한 것으로, 보다 구체적으로는 포도상구균 (Staphylococcus aureus)으로부터 정제된 WTA를 유효성분으로 함유하는 포도상구균 감염 예방용 백신 조성물에 관한 것이다. 본 발명에 따른 백신 조성물을 MBL 및/또는 항-WTA 항체가 존재하지 않거나, 저 농도로 존재하는 개체, 특히 소아에 접종하는 경우 급성 호흡기 감염과 같은 포도상구균의 감염을 효과적으로 예방할 수 있는 효과가 있다.
PCT/KR2011/003450 2010-05-10 2011-05-11 Ｗｔａ를 유효성분으로 함유하는 백신 조성물 WO2011142573A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0043631 2010-05-10
KR1020100043631A KR20110124060A (ko) 2010-05-10 2010-05-10 Ｗｔａ를 유효성분으로 함유하는 백신 조성물

Publications (2)

Publication Number Publication Date
WO2011142573A2 WO2011142573A2 (ko) 2011-11-17
WO2011142573A3 true WO2011142573A3 (ko) 2012-03-29

Family

ID=44914808

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/003450 WO2011142573A2 (ko) 2010-05-10 2011-05-11 Ｗｔａ를 유효성분으로 함유하는 백신 조성물

Country Status (2)

Country Link
KR (1) KR20110124060A (ko)
WO (1) WO2011142573A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101459186B1 (ko) * 2012-04-26 2014-11-07 울산대학교 산학협력단 지속적 황색포도알균 균혈증의 조기 진단용 조성물 및 조기 진단방법
WO2013168965A2 (ko) * 2012-05-07 2013-11-14 목암생명공학연구소 포도상구균 감염 예방용 백신 조성물
KR20170005852A (ko) * 2014-05-29 2017-01-16 주식회사 녹십자 포도상구균 감염 질환의 예방 또는 치료용 조성물
WO2017010845A1 (ko) * 2015-07-15 2017-01-19 재단법인 목암생명과학연구소 포도상구균 감염 질환의 예방 또는 치료용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247605A1 (en) * 2002-12-02 2004-12-09 Kokai-Kun John Fitzgerald Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040247605A1 (en) * 2002-12-02 2004-12-09 Kokai-Kun John Fitzgerald Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEIDENMAIER, C. ET AL.: "Role ofteichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections", NATURE MEDICINE, vol. 10, no. 3, 2004, pages 243 - 245, XP002450716 *

Also Published As

Publication number Publication date
KR20110124060A (ko) 2011-11-16
WO2011142573A2 (ko) 2011-11-17

Similar Documents

Publication Publication Date Title
CL2013001316A1 (es) Composicion que comprende micro-organismo probioticos no replicantes que protegen contra las infecciones del tracto respiratorio superior.
EA201590890A1 (ru) Производные 5-фтор-n-(пиридин-2-ил)пиридин-2-амина, содержащие сульфоксиминовую группу
EA201500386A1 (ru) Пестицидные смеси, содержащие жасмоновую кислоту или её производное
MX2013005478A (es) Compuestos heterociclicos condensados antivirales.
MX336189B (es) Compuesto de dihidroazol antiparasiticos y composiciones qe¡ue comprenden los mismos.
WO2011158044A3 (en) Respiratory formulations containing p38 mapk inhibitors
WO2013091775A3 (de) Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe
WO2010084115A3 (en) Antiviral agents
WO2010111640A3 (en) Anti-influenza formulations and methods
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
WO2013168965A3 (ko) 포도상구균 감염 예방용 백신 조성물
WO2011142573A3 (ko) Ｗｔａ를 유효성분으로 함유하는 백신 조성물
MX2016001855A (es) Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio.
WO2011006935A3 (en) Tetrazole derivatives
MX2016006216A (es) Formulas infantiles que contienen un oligosacarido 2-fucosilado para el tratamiento o la prevencion de una infeccion de influenza.
WO2008146172A3 (en) Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
WO2014064652A3 (en) Stable pharmaceutical composition of peginterferon alpha-2b
WO2013166282A3 (en) Methods and compositions for treating bacterial infection
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
WO2014057415A3 (en) Inhibitors of dna gyrase for the treatment of bacterial infections
PH12017501505B1 (en) Respiratory infection treating agent
BR112013028698A8 (pt) Compostos para uso no tratamento de infecções retrovirais em felinos
WO2012006321A3 (en) Novel antibacterial compounds, methods of making them, and uses thereof
BR112012006250A2 (pt) composições e métodos para o tratamento de infecções bacterianas usando ceftaroline
WO2011095768A8 (en) Lantibiotic salts

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11780790

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11780790

Country of ref document: EP

Kind code of ref document: A2